Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2025-12-26 @ 1:47 AM
NCT ID: NCT02402933
Description: All participants who received at least one dose of NG, including GCP non-compliance site. Adverse events were collected systematically using the Hypoglycemia Questionnaire.
Frequency Threshold: 0
Time Frame: None
Study: NCT02402933
Study Brief: Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Nasal Glucagon 3 mg glucagon powder None None 0 22 20 22 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Paranasal Sinus Hypersecretion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (17.1) View
Product Taste Abnormal SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Tremor SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Watery Eyes SYSTEMATIC_ASSESSMENT Eye disorders Questionnaire View
Sneezing SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (17.1) View
Abdominal Pain Upper SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Face Injury SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.1) View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Headache SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Hyperhidrosis SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.1) View
Incomplete Dose Administered SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View
Nasal Discomfort SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders Questionnaire View
Rhinorrhoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (17.1) View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View